Effect of intravenous zoledronic acid on histopathology and recurrence after extended curettage in giant cell tumors of bone: A comparative prospective study
Conclusions: We observed that bisphosphonates reduce osteoclast activity and affects stromal cells in GCT, resulting in the reduction of their numbers and noticeable apoptosis. This results in better marginalization of the lesions and reduced recurrence. Extended curettage of friable GCT became easier and adequate which otherwise might not have been possible.
Source: Indian Journal of Orthopaedics - Category: Orthopaedics Authors: Zile Singh Kundu Rajeev Sen Ankur Dhiman Pankaj Sharma Ramchander Siwach Parveen Rana Source Type: research
More News: Cancer | Cancer & Oncology | India Health | Orthopaedics | Osteoporosis | Reclast | Study | Zometa